AAN 2024 Fall Conference On Demand

AAN 2024 Fall Conference On Demand The 2024 AAN Fall Conference in Las Vegas and online was October 25–27. Access content from the meeting

2024 Fall Conference On Demand includes:

2024 Fall Conference

as of 11/16/2024 05:01 AM

Search Filters:

Event Types: Programs, ICWs, Events

Thursday 10/24/24

8:00 AM-5:00 PM PDT APP – AAN Advanced Practice Provider Neurology Conference
Friday 10/25/24
8:00 AM-9:00 AM PDT

C1 – Opening Keynote: Myelin Oligodendrocyte Glycoprotein

Antibody Disorders (MOGAD)
9:00 AM-9:30 AM PDT Break
9:30 AM-11:00 AM PDT C2 – Neurology Update 1: Multiple Sclerosis; Headache
9:30 AM-11:00 AM PDT

C3 – Neuromuscular Junction Disorders: Myasthenia Gravis, Ocular,
and MuSK Myasthenia
9:30 AM-11:00 AM PDT

C4 – Practice Management 1: From Chatroom to Care Continuum:
Elevating Patient Engagement Beyond Visits9:30 AM-11:00 AM PDT L1 – Knowing and Communicating Your Value
11:00 AM-1:00 PM PDT Exhibit Hall Lunch
1:00 PM-2:30 PM PDT C5 – Neurology Update 2: Sleep; Brain Death
1:00 PM-2:30 PM PDT C6 – Anti-amyloid Therapy Update
1:00 PM-2:30 PM PDT

C7 – Practice Management 2: Beyond the Basics: Optimizing the
Onboarding Experience for New APPs
1:00 PM-2:30 PM PDT

L2 – Leading from Where You Are: How to Advocate for Change at
Any Level
B k
2:30 PM-3:00 PM PDT Break
3:00 PM-4:30 PM PDT

C10 – Practice Management 3: New Frontiers in Care: Exploring
Innovative Service Lines for Community Practices
3:00 PM-4:30 PM PDT C8 – Neurology Update 3: Dementia; Cerebrovascular Disease
3:00 PM-4:30 PM PDT C9 – Controversies in Neurology
3:00 PM-4:30 PM PDT

L3 – Emotional Intelligence in Action: Navigating Conflict in
Difficult Times
4:00 PM-5:30 PM PDT Exhibit Hall Reception

Saturday 10/26/24

7:00 AM-7:50 AM PDT
Industry Therapeutic Update from Biogen: SKYCLARYS®
(omaveloxolone) The First and Only FDA-Approved Prescription
Treatment for Friedreich Ataxia in Adults and Adolescents Aged 16
Years and Older

8:00 AM-9:30 AM PDT

C11 – Neurology Update 4: Movement Disorders; Autonomic
Disorders
8:00 AM-9:30 AM PDT C12 – Neuromyelitis Optica Spectrum Disorders
8:00 AM-9:30 AM PDT

C13 – Practice Management 4: From Payers to Partners: Strategies to
Reduce Burden and Build Collaboration
9:30 AM-10:00 AM PDT Exhibit Hall Break
10:00 AM-11:30 AM PDT

C14 – Neurological Debate: Should Patients with a Single
Unprovoked Seizure be Evaluated and Treated as if They Have
Epilepsy?
10:00 AM-11:30 AM PDT C15 – Chronic Inflammatory Demyelinating Polyneuropathy
10:00 AM-11:30 AM PDT

C16 – Practice Management 5: Don’t Leave Money on the Table:
Optimize Inpatient Coding with Refresher and Novel Codes
11:30 AM-1:00 PM PDT Exhibit Hall Lunch
12:00 PM-1:00 PM PDT

Industry Therapeutic Update from Eli Lilly: Explore a New Therapy
for Early Symptomatic Alzheimer’s Disease
1:00 PM-2:30 PM PDT

C17 – Neurology Update 5: Neuroimmunology and Infectious
Disease; Neurohospitalist
1:00 PM-2:30 PM PDT

C18 – Neurology Education: Teaching on the Go: Effective
Strategies for Busy Neurology Providers
1:00 PM-2:30 PM PDT

C19 – Practice Management 6: Beyond the Bedside: Bite-sized
Strategies for Value-based Care Success
1:00 PM-4:30 PM PDT

C20 – Skills Workshop: Neurological Examination Skills for
Advanced Practice Providers
2:30 PM-3:00 PM PDT Break
3:00 PM-4:30 PM PDT

C21 – Neurology Update 6: Neurology in Vulnerable Populations;
Functional Neurology
3:00 PM-4:30 PM PDT C22 – Clinical Trials Update
3:00 PM-4:30 PM PDT

C23 – Practice Management 7: AI on Monday Mornings: Practical
Applications for Busy MDs & BAs

Sunday 10/27/24

7:30 AM-9:00 AM PDT C24 – Neurology Update 7: Neuromuscular Disease; Epilepsy
7:30 AM-9:00 AM PDT C25 – Neuro-rheumatology
9:00 AM-9:30 AM PDT Break

9:30 AM-11:00 AM PDT C26 – Neurology Update 8: Neuro-oncology; Neuro-ophthalmology
9:30 AM-11:00 AM PDT

C27 – Trigeminal Neuralgia: Mimics, Pharmacotherapy, and
Surgical/Interventional Treatmen

 

 

 

 

Topics:

• C1 Opening Keynote Myelin Oligodendrocyte Glycoprotein Antibody Disorders (MOGAD).ts
• C2 Neurology Update 1 Multiple Sclerosis; Headache 2024 Headache Update.ts
• C2 Neurology Update 1 Multiple Sclerosis; Headache Multiple Sclerosis.ts
• C2 Neurology Update 1 Multiple Sclerosis; Headache Question & Answer.ts
• C3 Neuromuscular Junction Disorders Myasthenia Gravis, Ocular, and MuSK Myasthenia Acetylcholine Receptor Antibody Positive Myasthenia Gravis.ts
• C3 Neuromuscular Junction Disorders Myasthenia Gravis, Ocular, and MuSK Myasthenia Challenging-Cases-from-Clinical-Practice.png
• C3 Neuromuscular Junction Disorders Myasthenia Gravis, Ocular, and MuSK Myasthenia Ocular and MuSK Myasthenia Gravis.ts
• C3 Neuromuscular Junction Disorders Myasthenia Gravis, Ocular, and MuSK Myasthenia Questions and Answers.ts
• C3 Neuromuscular Junction Disorders Myasthenia Gravis, Ocular, and MuSK Myasthenia Targeted Therapy in MG- Complement and FcRn Inhibition.ts
• C4 Practice Management 1 From Chatroom to Care Continuum Elevating Patient Engagement Beyond Visits.ts
• C5 Neurology Update 2 Sleep; Brain Death Brain Death.ts
• C5 Neurology Update 2 Sleep; Brain Death Neurology Meets Sleep- Streamlining Diagnoses and Revamping Treatments for RLS, OSA, and Insomnia.ts
• C5 Neurology Update 2 Sleep; Brain Death Question & Answer.ts
• C6 Anti-amyloid Therapy Update ARIA.ts
• C6 Anti-amyloid Therapy Update Lessons Learned from One Year of Availability and Cases.ts
• C6 Anti-amyloid Therapy Update Overview of Trials and Updates.ts
• C6 Anti-amyloid Therapy Update Question & Answer.ts
• C7 Practice Management 2 Beyond the Basics Optimizing the Onboarding Experience for New APPs.ts
• C8 Neurology Update 3 Dementia; Cerebrovascular Disease Cerebrovascular Disease.ts
• C8 Neurology Update 3 Dementia; Cerebrovascular Disease Dementia.ts
• C8 Neurology Update 3 Dementia; Cerebrovascular Disease Question & Answer.ts
• C9 Controversies in Neurology AI Powered Automated EEG- Supervision Needed.ts
• C9 Controversies in Neurology Is a Picture Worth a Thousand Treatments- Treating the Silent Vascular Lesion.ts
• C10 Practice Management 3 New Frontiers in Care Exploring Innovative Service Lines for Community Practices.ts
• C11 Neurology Update 4 Movement Disorders; Autonomic Disorders Movement Disorders.ts
• C11 Neurology Update 4 Movement Disorders; Autonomic Disorders Question & Answer.ts
• C11 Neurology Update 4 Movement Disorders; Autonomic Disorders Updates in Autonomic Disorders.ts
• C12 Neuromyelitis Optica Spectrum Disorders AQP4-IgG- The Impact and Evolution of Serodiagnosis.ts
• C12 Neuromyelitis Optica Spectrum Disorders Biomarkers in NMOSD- Can We Measure Treatment Response.ts
• C12 Neuromyelitis Optica Spectrum Disorders Faculty-Audience Discussion.ts
• C12 Neuromyelitis Optica Spectrum Disorders NMOSD- Acute and Preventative Treatments in the Era of Registered Therapies.ts
• C13 Practice Management 4 From Payers to Partners Strategies to Reduce Burden and Build Collaboration.ts
• C14 Neurological Debate Should Patients with a Single Unprovoked Seizure be Evaluated and Treated as if They Have Epilepsy Discussion.ts
• C14 Neurological Debate Should Patients with a Single Unprovoked Seizure be Evaluated and Treated as if They Have Epilepsy Should Patients with a Single Unprovoked Seizure be Evaluated and Treated as if They Have Epilepsy (no).ts
• C14 Neurological Debate Should Patients with a Single Unprovoked Seizure be Evaluated and Treated as if They Have Epilepsy Should Patients with a Single Unprovoked Seizure be Evaluated and Treated as if They Have Epilepsy (yes).ts
• C15 Chronic Inflammatory Demyelinating Polyneuropathy Questions and Answers.ts
• C15 Chronic Inflammatory Demyelinating Polyneuropathy The Clinical Presentation and Diagnosis of CIDP.ts
• C15 Chronic Inflammatory Demyelinating Polyneuropathy The Therapeutic Approach to CIDP.ts
• C16 Practice Management 5 Don’t Leave Money on the Table Optimize Inpatient Coding with Refresher and Novel Codes.ts
• C17 Neurology Update 5 Neuroimmunology and Infectious Disease; Neurohospitalist Neurohospitalist.ts
• C17 Neurology Update 5 Neuroimmunology and Infectious Disease; Neurohospitalist Neuroimmunology and Infectious Disease.ts
• C17 Neurology Update 5 Neuroimmunology and Infectious Disease; Neurohospitalist Question & Answer.ts
• C18 Neurology Education Teaching on the Go Effective Strategies for Busy Neurology Providers Introduction & Storysetting.ts
• C18 Neurology Education Teaching on the Go Effective Strategies for Busy Neurology Providers Large Group Debrief.ts
• C18 Neurology Education Teaching on the Go Effective Strategies for Busy Neurology Providers Practical Application.ts
• C18 Neurology Education Teaching on the Go Effective Strategies for Busy Neurology Providers Small Group Work.ts
• C19 Practice Management 6 Beyond the Bedside Bite-sized Strategies for Value-based Care Success 1.ts
• C19 Practice Management 6 Beyond the Bedside Bite-sized Strategies for Value-based Care Success 2.ts
• C21 Neurology Update 6 Neurology in Vulnerable Populations; Functional Neurology Functional Neurological Disorder.ts
• C21 Neurology Update 6 Neurology in Vulnerable Populations; Functional Neurology Neurology in Vulnerable Populations.ts
• C21 Neurology Update 6 Neurology in Vulnerable Populations; Functional Neurology Question & Answer.ts
• C22 Clinical Trials Update Gene Transfer Therapy- Is it Safe.ts
• C22 Clinical Trials Update Migraine Management in Special Populations.ts
• C22 Clinical Trials Update The Current State of Long-COVID- Clinical Trials and Ethical Aspects.ts
• C23 Practice Management 7 AI on Monday Mornings Practical Applications for Busy MDs & BAs.ts
• C24 Neurology Update 7 Neuromuscular Disease; Epilepsy Epilepsy.ts
• C24 Neurology Update 7 Neuromuscular Disease; Epilepsy Neuromuscular Disease.ts
• C24 Neurology Update 7 Neuromuscular Disease; Epilepsy Question & Answer.ts
• C25 Neuro-rheumatology Case-based Discussions in Neuro-rheumatology (1).ts
• C25 Neuro-rheumatology Case-based Discussions in Neuro-rheumatology (2).ts
• C25 Neuro-rheumatology Pawate – Case 2.ts
• C25 Neuro-rheumatology Questions and Answers.ts
• C26 Neurology Update 8 Neuro-oncology; Neuro-ophthalmology Neuro-oncology.ts
• C26 Neurology Update 8 Neuro-oncology; Neuro-ophthalmology Neuro-ophthalmology.ts
• C26 Neurology Update 8 Neuro-oncology; Neuro-ophthalmology Question & Answer.ts
• C27 Trigeminal Neuralgia Mimics, Pharmacotherapy, and SurgicalInterventional Treatment Interventional-Surgical Management of Trigeminal Neuralgia.ts
• C27 Trigeminal Neuralgia Mimics, Pharmacotherapy, and SurgicalInterventional Treatment Pathophysiology, Diagnosis, Pharmacological Management of Trigeminal Neuralgia.ts
• C27 Trigeminal Neuralgia Mimics, Pharmacotherapy, and SurgicalInterventional Treatment Questions and Answers.ts
• C27 Trigeminal Neuralgia Mimics, Pharmacotherapy, and SurgicalInterventional Treatment Trigeminal Neuralgia Mimics- Headache and Orofacial Pain Differential Diagnosis and Management.ts
• L1 Knowing and Communicating Your Value Knowing and Communicating Your Value.ts
• L2 Leading from Where You Are How to Advocate for Change at Any Level How to Lead When You’re Not the Leader 1.ts
• L2 Leading from Where You Are How to Advocate for Change at Any Level How to Lead When You’re Not the Leader 2.ts